Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
17/11/2025 15:42
Nov 17 (Reuters) - Lavipharm SA LPHr.AT: 9-MONTH NET PROFIT EUR 3.5 MILLION VERSUS EUR 9.2 MILLION YEAR AGO 9-MONTH ADJUSTED EBITDA EUR 10.5 MILLION VERSUS EUR 9.4 MILLION YEAR AGO 9-MONTH TOTAL SALES BEFORE CLAWBACK-REBATES EUR 47.7 MILLION VERSUS EUR 45.5 MILLION YEAR AGO DECLINE IN EXPORTS CONSIDERED TEMPORARY EXPECTS DOWNWARD TREND IN EXPORTS TO FULLY REVERSE IN Q4 Further company coverage: [LPHr.AT] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY